Whitehawk Therapeutics, Inc. — Director's Dealing 2021

Jun 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aerpio Pharmaceuticals, Inc. (ARPO)
CIK: 0001422142
Period of Report: 2021-06-17

Reporting Person: Cohen Cheryl (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-17	Stock Option (Right to Buy)	$1.87	A	100000	Acquired	2031-06-17	Common Stock (100000)	Direct

Footnotes

F1: This option is fully vested.